See more : Citius Pharmaceuticals, Inc. (CTXR) Income Statement Analysis – Financial Results
Complete financial analysis of Transchem Limited (TRANSCHEM.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Transchem Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Bradda Head Lithium Limited (BHLIF) Income Statement Analysis – Financial Results
- Raffles Medical Group Ltd (BSL.SI) Income Statement Analysis – Financial Results
- AccuStem Sciences Limited (ACMSY) Income Statement Analysis – Financial Results
- Mandalay Resources Corporation (MND.TO) Income Statement Analysis – Financial Results
- MSD Acquisition Corp. (MSDAW) Income Statement Analysis – Financial Results
Transchem Limited (TRANSCHEM.BO)
About Transchem Limited
Transchem Ltd. engages in the production and processing of mushroom. Its mushroom plants are located at Talegaon village, Taluka Maval and District Pune. The company was founded on November 18, 1976 and is headquartered in Thane, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 275.32M |
| Cost of Revenue | 13.07M | 7.09M | 6.89M | 8.15M | 6.64M | 4.76M | 2.84M | 2.06M | 1.93M | 899.00 | 73.10K | 183.25K | 0.00 | 0.00 | 0.00 | 0.00 | 131.53M |
| Gross Profit | -8.97M | -7.09M | -6.89M | -8.15M | -6.64M | -4.76M | -2.84M | -2.06M | -1.93M | -899.00 | -73.10K | -183.25K | 0.00 | 0.00 | 0.00 | 0.00 | 143.80M |
| Gross Profit Ratio | -218.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 52.23% |
| Research & Development | 0.00 | 0.00 | 0.00 | 2.10M | 0.00 | 0.00 | 500.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.69M | 6.20M | 15.18M | 5.62M | 2.53M | 2.85M | 2.81M | 2.72M | 4.07M | 5.19M | 7.03M | 15.08M | 38.67M | 25.35M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 26.00K | 26.00K | 28.00K | 28.00K | 54.92K | 92.24K | 94.91K | 53.58K | 57.30K | 151.70K | 55.77K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.72M | 6.23M | 15.21M | 5.65M | 2.59M | 2.94M | 2.90M | 2.77M | 4.13M | 5.19M | 7.03M | 15.08M | 38.67M | 25.35M | 0.00 | 0.00 | 0.00 |
| Other Expenses | -10.00K | 54.00K | 11.05M | 64.00K | 24.06K | -200.00K | -5.72M | 3.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 25.00K |
| Operating Expenses | 8.47M | 8.61M | 17.85M | 11.94M | 13.03M | 13.61M | 21.41M | 15.82M | 17.54M | 18.55M | 25.69M | 35.20M | 57.11M | 43.51M | 48.38M | 38.77M | 171.88M |
| Cost & Expenses | 21.54M | 15.71M | 24.74M | 20.08M | 19.67M | 18.37M | 24.25M | 17.88M | 19.47M | 18.55M | 25.69M | 35.20M | 57.11M | 43.51M | 48.38M | 38.77M | 303.41M |
| Interest Income | 73.68M | 40.45M | 54.54M | 43.47M | 27.09M | 24.64M | 9.80M | 0.00 | 0.00 | 0.00 | 351.29K | 452.54K | 0.00 | 0.00 | 130.54K | 69.54K | 113.71K |
| Interest Expense | 1.00K | 3.00K | 1.00K | 13.00K | 1.96K | 94.00 | 1.82K | 821.00 | 723.00 | 0.00 | 464.92K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 81.00K | 78.00K | 78.00K | 1.24M | 5.73M | 7.99M | 9.69M | 10.18M | 10.18M | 10.75M | 15.21M | 15.36M | 15.30M | 15.29M | 15.13M | 14.80M | 18.91M |
| EBITDA | 56.61M | -15.63M | -15.62M | 248.94M | -13.93M | -11.03M | -16.92M | 7.99M | -9.29M | -7.80M | -10.42M | 4.81M | -20.88M | -16.95M | -13.16M | 156.60K | -9.17M |
| EBITDA Ratio | 1,380.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -30.72% |
| Operating Income | -17.44M | -17.40M | -27.52M | -20.59M | -19.67M | -19.16M | -26.61M | -570.70K | 467.96K | 1.18M | -7.74M | -13.16M | -38.15M | -32.82M | -28.29M | -14.49M | 54.46M |
| Operating Income Ratio | -425.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 19.78% |
| Total Other Income/Expenses | 73.97M | 42.44M | 66.60M | 280.50M | 10.71M | 13.76M | 3.18M | 1.04M | 9.48M | 8.98M | 2.68M | 21.53M | -1.00 | 11.58M | 20.09M | 24.73M | 82.40M |
| Income Before Tax | 56.53M | 25.04M | 39.08M | 247.70M | 7.93M | 7.75M | -5.50M | -2.19M | 189.10K | 1.18M | -7.74M | -13.16M | -38.15M | -32.82M | -28.29M | -14.49M | 54.46M |
| Income Before Tax Ratio | 1,378.78% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 19.78% |
| Income Tax Expense | 14.50M | 12.67M | 10.40M | 6.20M | 3.83M | 4.70M | 6.40M | 19.61M | -278.86K | -18.59M | 300.00K | -42.91M | -4.78M | -4.75M | -8.21M | -3.47M | 19.43M |
| Net Income | 42.03M | 12.37M | 28.68M | 241.50M | 4.10M | 3.05M | -11.90M | -2.19M | 467.96K | 1.18M | -8.04M | -13.16M | -33.37M | -28.07M | -20.08M | -11.02M | 34.29M |
| Net Income Ratio | 1,025.22% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 12.45% |
| EPS | 3.43 | 1.01 | 2.34 | 19.73 | 0.33 | 0.25 | -0.97 | -0.18 | 0.04 | 0.10 | -0.66 | -1.08 | -2.73 | -2.29 | -1.64 | -0.90 | 2.80 |
| EPS Diluted | 3.43 | 1.01 | 2.34 | 19.73 | 0.33 | 0.25 | -0.97 | -0.18 | 0.04 | 0.10 | -0.66 | -1.08 | -2.73 | -2.29 | -1.64 | -0.90 | 2.80 |
| Weighted Avg Shares Out | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M |
| Weighted Avg Shares Out (Dil) | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M | 12.24M |
No news found for: TRANSCHEM.BO
Source: https://incomestatements.info
Category: Stock Reports